Skip to main content
. 2022 Aug 15;13:4728. doi: 10.1038/s41467-022-32390-1

Fig. 4. DREADD-β2AR recruits β-arrestin 2-and phosphorylates ERK1/2.

Fig. 4

a Schematic of induced bioluminescence upon GPCR-SmBiT and β-arrestin 2-LgBiT interaction. GPCR, G protein-coupled receptor. HSV-TK, herpes simplex virus thymidine kinase promoter. b Real-time measurement of bioluminescence in HEK cells transfected with non-chimeric β2AR (left) or DREADD-β2AR (right). Baseline measurements followed by ligand application (gray arrow shows onset) of either levalbuterol (left) or CNO (right). Measure of center: Mean of baseline-normalized fold change compared to vehicle (dashed line) in the same experimental repetition. Ribbons: 95% confidence intervals. N = four (Non-chimeric β2AR) or five (DREADD-β2AR) experimental repetitions. Source data are provided as a Source Data file. c Phosphorylation analysis of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in untreated, levalbuterol- or CNO-treated HEK cells transfected with non-chimeric β2AR, DREADD-β2AR, or empty vector. Left: Western blot for pERK1/2 and GAPDH (loading control). The anti-pERK1/2 antibody results in an upper band for pERK1 (44 kDa) and a lower band for pERK2 (42 kDA). Right: Densitometry analysis of combined pERK1/2 normalized to GAPDH. Error bars: standard error of the mean. N = three experimental repetitions. Supplementary Fig. S4 shows full scan Western blot membranes from all repetitions. Source data are provided as a Source Data file.